Mirion Q2 revenue beats analyst estimates, raises FY guidance

Overview

• Mirion Q2 revenue grows 7.6%, beating analyst expectations, per LSEG data

• Adjusted EPS for Q2 rises to $0.11

• Co raises full-year guidance for revenue, EBITDA, free cash flow, and adjusted EPS

Outlook

• Mirion raises 2025 revenue growth guidance to 7%-9% from 5%-7%

• Company expects 2025 adjusted EBITDA of $223 mln-$233 mln

• Mirion forecasts 2025 adjusted EPS of $0.48-$0.52 per share

• Company sees 2025 adjusted free cash flow at $95 mln-$115 mln

Result Drivers

• NUCLEAR AND CANCER CARE - Favorable market dynamics in nuclear power and cancer care positively impacted strategic positioning and operating performance, per CEO Thomas Logan

• TARIFF MINIMIZATION - Co successfully minimized tariff exposure, contributing to improved operating performance

• CAPITAL STRUCTURE ENHANCEMENTS - Refinancing and Certrec acquisition optimized capital structure and expanded offerings in nuclear power and broader energy markets

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

• Wall Street's median 12-month price target for Mirion Technologies Inc is $22.00, about 1.9% below its July 30 closing price of $22.42

• The stock recently traded at 42 times the next 12-month earnings vs. a P/E of 30 three months ago

Press Release: ID:nBw6Bl8Bka